βk-2C-B
βk-2C-B (beta-keto 2C-B, bk-2C-B) is a psychedelic drug which is structurally related to 2C-B and BOB[1] and has been sold online as a designer drug.[2] It was found to be a polymorph and is prone to selfcondensation forming a dimer under basic to neutral conditions, similar to the reaction involved in pyrazine synthesis.[3]
![]() | |
Clinical data | |
---|---|
Routes of administration | Oral |
Legal status | |
Legal status |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
Chemical and physical data | |
Formula | C10H12BrNO3 |
Molar mass | 274.111 g/mol (freebase) 310.572 g/mol (HCl salt) g·mol−1 |
3D model (JSmol) | |
| |
|
Analogues and derivatives
Analogues and derivatives of 2C-B:
- 2C-B-FLY
- 2CBFly-NBOMe (NBOMe-2CB-Fly)
Other:
- 2C-B-AN
- 2C-B-BUTTERFLY
- 2C-B-DragonFLY
- 2CB-5-hemifly
- 2CB-Ind
- βk-2C-B (beta-keto 2C-B)
- TCB-2 (2C-BCB)
Legal status
Canada
As of 12 October 2016, βk-2C-B became a controlled substance (Schedule III) in Canada.[4]
gollark: ŧħøße łħø ðø nøŧ ðø nøŧ ðeßerve øur þrøðu¢ŧ.
gollark: ¥E§
gollark: <@341618941317349376> Currying > Multi-arity functions.
gollark: <@337621533369303042> be "Anybody"
gollark: Do you know <@!330678593904443393> else who thinks so?
References
- Richard A. Glennon; Mikhail L. Bondarev; Nantaka Khorana; Richard Young; Jesse A. May; Mark R. Hellberg; Marsha A. McLaughlin; Najam A. Sharif (November 2004). "β-Oxygenated Analogues of the 5-HT2A Serotonin Receptor Agonist 1-(4-Bromo-2,5-dimethoxyphenyl)-2-aminopropane". Journal of Medicinal Chemistry. 47 (24): 6034–6041. doi:10.1021/jm040082s. PMID 15537358.
- Giampietro Frison; Sara Odoardi; Samuela Frasson; Rocco Sciarrone; Giorgio Ortar; Francesco Saverio Romolo; Sabina Strano Rossi (July 2015). "Characterization of the designer drug bk-2C-B (2-amino-1-(bromo-dimethoxyphenyl)ethan-1-one) by gas chromatography/mass spectrometry without and with derivatization with 2,2,2-trichloroethyl chloroformate, liquid chromatography/high-resolution mass spectrometry, and nuclear magnetic resonance". Rapid Communications in Mass Spectrometry. 29 (13): 1196–1204. doi:10.1002/rcm.7211. PMID 26395784.
- John D. Power; Pierce Kavanagh; John O'Brien; Michael Barry; Brendan Twamley; Brian Talbot; Geraldine Dowling; Simon D. Brandt (June 2015). "Test purchase, identification and synthesis of 2-amino-1-(4-bromo-2, 5-dimethoxyphenyl)ethan-1-one (bk-2C-B)". Drug Testing and Analysis. 7 (6): 512–518. doi:10.1002/dta.1699. PMID 25078895.
- "Regulations Amending the Food and Drug Regulations (Part J — 2C-phenethylamines)". Controlled Substances Act. 2016-05-04.
- "Verordnung des EDI über die Verzeichnisse der Betäubungsmittel, psychotropen Stoffe, Vorläuferstoffe und Hilfschemikalien" (in German). Der Bundesrat.
- "Nya substanser klassas som narkotika eller hälsofarlig vara" (in Swedish). Folkhälsomyndigheten. 18 August 2015.
- "Psychoactive Substances Act 2016". Home Office. Retrieved 8 September 2016.
Phenethylamines |
|
---|---|
Amphetamines |
|
Phentermines |
|
Cathinones |
|
Phenylisobutylamines | |
Phenylalkylpyrrolidines | |
Catecholamines (and close relatives) |
|
Miscellaneous |
|
Psychedelics (5-HT2A agonists) |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dissociatives (NMDAR antagonists) |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Deliriants (mAChR antagonists) |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Others |
|
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.